Gao Feng, Zhang Yang, Wang Li-Kun, Wei Yong-Li, Wang Jing-Wei, Wang Cheng-Bao, Li Qiang
1 Department of Infectious Disease, Linyi People's Hospital , Linyi, Shandong, People's Republic of China .
Genet Test Mol Biomarkers. 2015 Apr;19(4):218-21. doi: 10.1089/gtmb.2014.0096. Epub 2014 Oct 17.
This study sought to use a meta-analysis approach to comprehensively evaluate correlations between the human leukocyte antigen-DR beta 1 (HLA-DRB1)*03 allele and chronic hepatitis B (CHB) in the Han Chinese population.
The China Biomedical Literature database (CBMdisc), the Chongqing VIP database (VIP), and the PubMed database were searched. Using the inclusion and exclusion criteria of this study, all relevant case-control studies retrieved in these searches that satisfied the conditions of this investigation were collected. Review Manager (RevMan) 5.2 software was used to conduct a meta-analysis on the results of these studies.
There were 9 publications that satisfied the inclusion criteria. These publications included a total of 970 cases in the CHB group and 1185 cases in the normal control group. Egger's test revealed no significant publication bias. A comprehensive analysis indicated that the pooled odds ratio (OR) value was 1.94 with a 95% confidence interval (CI) of 1.23-3.06 (Z=2.84, p=0.004); these findings suggested that in the Han Chinese population, the HLA-DRB1*03 allele is a susceptibility allele related to the occurrence of CHB.
There is a statistically significant correlation between the HLA-DRB103 allele and the occurrence of CHB in the Han Chinese population, and the HLA-DRB103 allele may be a susceptibility allele for this disease.
本研究旨在采用荟萃分析方法,全面评估人类白细胞抗原-DRβ1(HLA-DRB1)*03等位基因与汉族人群慢性乙型肝炎(CHB)之间的相关性。
检索中国生物医学文献数据库(CBMdisc)、重庆维普数据库(VIP)和PubMed数据库。根据本研究的纳入和排除标准,收集这些检索中检索到的所有符合本研究条件的相关病例对照研究。使用Review Manager(RevMan)5.2软件对这些研究结果进行荟萃分析。
有9篇出版物符合纳入标准。这些出版物中,CHB组共有970例,正常对照组有1185例。Egger检验显示无显著发表偏倚。综合分析表明,合并比值比(OR)值为1.94,95%置信区间(CI)为1.23 - 3.06(Z = 2.84,p = 0.004);这些结果表明,在汉族人群中,HLA-DRB1*03等位基因是与CHB发生相关的易感等位基因。
汉族人群中,HLA-DRB103等位基因与CHB的发生之间存在统计学显著相关性,且HLA-DRB103等位基因可能是该疾病的易感等位基因。